Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012;17(11):1475-81.
doi: 10.1634/theoncologist.2012-0223. Epub 2012 Aug 29.

Cancer patient disclosure and patient-doctor communication of complementary and alternative medicine use: a systematic review

Affiliations

Cancer patient disclosure and patient-doctor communication of complementary and alternative medicine use: a systematic review

Esther L Davis et al. Oncologist. 2012.

Abstract

Objective: To explore the nondisclosure of complementary and alternative medicine (CAM) use among cancer patients, including reasons for and outcomes from nondisclosure of CAM use, within the context of patient-doctor communication.

Method: A systematic review was conducted exploring investigations surrounding the communication of CAM use for patients with cancer published until August 2011.

Results: A total of 21 studies were located, which reported a prevalence of CAM use among patients with cancer ranging between 11% and 95%; of these patients, 20% to 77% did not disclose their CAM use. The main reasons for nondisclosure were the doctor's lack of inquiry; patient's anticipation of the doctor's disapproval, disinterest, or inability to help; and patient's perception that disclosure of CAM use is irrelevant to their conventional care. There is some evidence to suggest that patient-doctor communication about the use of CAM was associated with an enhanced patient-doctor relationship and higher patient satisfaction.

Conclusions: Although the use of CAM by patients with cancer is high, patients frequently fail to disclose its use to their health professionals for reasons emanating from both sides of the dyadic patient-doctor relationship. Because a substantial proportion of patients with cancer may use CAM and there is potential for herb- or vitamin-drug interactions, further research in patient-doctor communication about CAM is necessary to maintain patient safety and wellbeing. The development of effective interventions to improve the disclosure of CAM use should be an integral part of this future research.

PubMed Disclaimer

Conflict of interest statement

Disclosures: The authors indicated no financial relationships.

Section Editors: Eduardo Bruera: None; Russell K. Portenoy: Arsenal Medical Inc., Pfizer, Grupo Ferrer, Transcript Pharma, Xenon (C/A); Allergan, Ameritox, Boston Scientific, Covidien Mallinckrodt Inc., Endo Pharmaceuticals, Forest Labs, K-Pax Pharmaceuticals, Medtronics, Otsuka Pharma, ProStrakan, Purdue Pharma, Salix, St. Jude Medical (RF)

Reviewer “A”: None

Reviewer “B”: None

Figures

Figure 1.
Figure 1.
Flow of information of the review.

Similar articles

Cited by

References

    1. U.S. Department of Health. National Health Interview Survey (NHIS) Washington, DC: U.S. Department of Health; 2002.
    1. Hyodo I, Amano N, Eguchi K, et al. Nationwide survey on complementary and alternative medicine in cancer patients in Japan. J Clin Oncol. 2005;23:2645–2654. - PubMed
    1. Jacobson JS, Workman SB, Kronenberg F. Research on complementary/alternative medicine for patients with breast cancer: A review of the biomedical literature. J Clin Oncol. 2000;18:668–683. - PubMed
    1. Owen DK, Lewith G, Stephens CR, et al. Can doctors respond to patients' increasing interest in complementary and alternative medicine? BMJ. 2001;322:154–158. - PMC - PubMed
    1. Mao J, Palmer C, Healy K, et al. Complementary and alternative medicine use among cancer survivors: A population-based study. J Cancer Surviv. 2011;5:8–17. - PMC - PubMed

Publication types